Low-dose hormone therapy and carbohydrate metabolism

Slides:

Advertisements

Similar presentations

Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial Marieke J.

Advertisements

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial Åsa Lindholm,

A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment Diane.

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study David F. Archer,

Jean L. Chan, MD, Martin J. Abrahamson, MD Mayo Clinic Proceedings

The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study Jeff G. Wang, M.D., Richard A. Anderson,

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate Wulf H Utian, M.D.,

Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women Bruce R. Carr, M.D.,

Reduction of C-reactive protein levels through use of a multivitamin

Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women Kai I. Cheang, Pharm.D., M.S., Paulina.

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment Diane.

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage.

Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic.

The spectrum of androgen excess disorders

Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regimen as postmenopausal hormone.

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study David F. Archer,

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy Peter Conner, M.D., Gunilla Svane, M.D., Ph.D.,

Temporal trends in clomiphene citrate use: a population-based study

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome Kelly Stamets,

Medical treatment of ectopic pregnancy: a committee opinion

Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth.

Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women Raymond W Ke,

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome Dorte Glintborg, M.D., Ph.D.,

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular.

Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial Wai Yee Wong, M.D, Ph.D., Hans.

Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled,

Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens

Jennifer Lucero, M. D. , Bernard L Harlow, Ph. D

Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence Jeffrey T. Jensen, M.D.,

The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study Gwinnett Ladson, M.D., William C. Dodson,

Yuan-qing Yao, M.D., Pak-chung Ho, M.D., William Shu-biu Yeung, Ph.D.

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

From partner's desk to iPad

The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study Seija Korhonen,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Ettore Cicinelli, M. D. , Louis J Ignarro, M. D. , Pietro Galantino, M

Effects of nonoral estradiol–micronized progesterone or low-dose oral estradiol– drospirenone therapy on metabolic variables and markers of endothelial.

Increased secretion of amylin in women with polycystic ovary syndrome

Hongxia Li, M. D. , Steven T Nakajima, M. D. , Jiangang Chen, M. D

Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization–embryo transfer Chung-Hoon Kim,

Regulation of assisted reproductive technologies in the United States

Cost-effectiveness of hysterosalpingography, laparoscopy, and Chlamydia antibody testing in subfertile couples Ben W.J Mol, M.D., Ph.D., John A Collins,

Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals Allison J. Tannis,

Naloxone decreases insulin secretion in hyperinsulinemic postmenopausal women and may positively affect hormone replacement therapy Francesco Cucinelli,

Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women Hong Zang, M.D., Kjell Carlström,

Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome Derek A Haas, M.D., Bruce.

Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men Subodhsingh Chauhan, M.D.,

Dijana Hadžiomerović, M. D. , Bernhard Rabenbauer, M. D

Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study Gwinnett Ladson,

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone.

Rupal Shroff, B. S. , Craig H. Syrop, M. D. , William Davis, M. D

Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight.

A critique of the Women’s Health Initiative hormone therapy study

Olav Istre, M.D., Ph.D., Birgitta Trolle, M.D. Fertility and Sterility

Anna Maria Fulghesu, M. D. , Mario Ciampelli, M. D. , Giuseppe Muzj, M

George Christodoulakos, M. D. , Irene Lambrinoudaki, M. D

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome C.J Glueck, M.D., Ping.

Low-dose conjugated equine estrogens elevate circulating neurotransmitters and improve the psychological well-being of menopausal women Arturo Zárate,

Effects of a single dose of oral estrogen on left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction Ali.

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy Helena J. Teede, Ph.D., Caroline Meyer, Ph.D.,

William R. Boone, Ph. D. , Jeffrey M. Jones, Ph. D. , Sander S

Thomas M Price, M.D., Susan Allen, R.N., G.Vernon Pegram, M.D.

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome Basak Yildirim, M.D., Nuran Sabir,

Presentation transcript:

Low-dose hormone therapy and carbohydrate metabolism Cairu Li, M.D., Göran Samsioe, M.D., Ph.D., Christer Borgfeldt, M.D., Ph.D., Pär-Ola Bendahl, Ph.D., Kittisak Wilawan, M.D., Anders Åberg, M.D., Ph.D. Fertility and Sterility Volume 79, Issue 3, Pages 550-555 (March 2003) DOI: 10.1016/S0015-0282(02)04762-3

FIGURE 1 Mean changes (%) of fasting glucose and fasting log-insulin in E2/NETA 0.5 mg group. ▩: fasting glucose; ■: fasting insulin. *P<.05 vs. baseline; **P<.01. Li. Low-dose HT and carbohydrate metabolism. Fertil Steril 2003. Fertility and Sterility 2003 79, 550-555DOI: (10.1016/S0015-0282(02)04762-3)

FIGURE 2 Insulin/glucose index at 12 months of treatments in three groups. Placebo ♦; E2/NETA 0.25 mg ■; E2/NETA 0.5 mg ▴. A significant drop in the index was found in both active treatment groups at 45, 60 and 90 minutes during OGTT when compared with the placebo group (P<.05). Li. Low-dose HT and carbohydrate metabolism. Fertil Steril 2003. Fertility and Sterility 2003 79, 550-555DOI: (10.1016/S0015-0282(02)04762-3)